Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

COVID-19 Clinical Trials

A listing of COVID-19 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (28) clinical trials

A Study to Evaluate the Efficacy Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy in Patients With Coronavirus Disease 19 (COVID-19)

The trial consists of a Phase 2 proof-of-concept phase (Part 1) with the option to extend enrollment (without interruption) to Phase 3 (Expansion Phase, Part 2). This trial is a multicenter, double-blind, placebo-controlled, randomized, parallel-group trial to evaluate the safety and efficacy of IMU-838 as addition to investigator's choice of …


Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure

The study is a 1:1 randomized, double-blind, placebo-controlled, Phase 2/3 trial to evaluate the safety and efficacy of DSTAT in adults with severe COVID-19 who are at high risk of respiratory failure. Eligible subjects will be those with confirmed COVID-19 who require hospitalization and supplemental oxygen therapy.


Ivermectin in Treatment of COVID-19

confirmed cases with COVID-19 will receive ivermectin as a therapeutic option as well as standard of care treatment and will be compared to those that will receive only standard of care ttt


Efficacay of Chloroquine in COVID-19 Treatment

Clinical Study Evaluating the Efficacy of Chloroquine in COVID-19 treatment


Antithrombotic Therapy to Ameliorate Complications of COVID-19 ( ATTACC )

This is a prospective, open-label, multicentre, Bayesian adaptive randomized clinical trial to establish whether therapeutic-dose parenteral anticoagulation improves outcomes for patients hospitalized with COVID-19 (e.g., reduces intubation or mortality). Participants will be randomized either to the investigational arm (therapeutic anticoagulation with heparin for 14 days or until "recovery" [defined as …


Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19

Main objective: To evaluate if HBO reduce the number of ICU admissions compared to Best practice for COVID-19 Secondary objectives: Main secondary objectives: To evaluate if HBO: reduces mortality in severe cases of COVID-19. reduces morbidity associated with COVID-19. reduce the load on ICU resources in COVID-19. mitigate the inflammatory …


ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19

This phase 2/3 study will evaluate the efficacy and safety of ABX464 50mg QD (oral capsule), on treating inflammation and preventing acute respiratory failure in patients infected with SARS-CoV-2. Eligible patients will be randomized according to a 2:1 ratio into 2 treatment cohorts as follows Standard of Care + Placebo …


The Efficacy of Ivermectin and Nitazoxanide in COVID-19 Treatment

Clinical Study Evaluating the Efficacy of Ivermectin and Nitazoxanide in COVID-19 treatment


A Real-life Experience on Treatment of Patients With COVID 19

COVID 19 treatment using Chloroquine with or without Azithromycin, Faviprevir, Nitazoxanide, Ivermectin on real life experience.


Oral 25-hydroxyvitamin D3 and COVID-19

Improvement in the vitamin D status i.e. total serum 25-hydroxyvitamin D in children and adults has been associated with reduced risk of upper respiratory tract infections including influenza A infection. The rationale for giving 25(OH)D3 rather than vitamin D3 is to rapidly improve the vitamin D status of the subjects …